Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 24, 2019
A successful case of venetoclax-based therapy in relapsed/refractory secondary plasma cell leukemiaAllison Kupsh, Justin Arnall, Peter VoorheesJournal of the Advanced Practitioner in Oncology|January 13, 2025
Advances in Myelofibrosis Management: New Janus Kinase Inhibitors Beyond RuxolitinibJustin Arnall, Lindsey Lyle, Donald C MooreJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 17, 2022
Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy SolutionsHouston Wyatt, Autumn D Zuckerman, Mitchell E Hughes, et al.Journal of Clinical & Translational Endocrinology|October 26, 2017
Impact of vitamin D status on statin-induced myopathyKrista D Riche, Justin Arnall, Kristin Rieser, et al.Journal of Thrombosis and Thrombolysis|January 6, 2020
Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experienceThuy Tran, Justin Arnall, Donald C Moore, et al.The Annals of Pharmacotherapy|October 1, 2021
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical PracticeAlana M Ciolek, Justin Arnall, Donald C Moore, et al.Contemporary Clinical Trials|April 5, 2021
Pharmacogenomics-guided supportive oncology: A tale of two trialsJai N Patel, Justin Arnall, Elizabeth Jandrisevits, et al.Journal of the Advanced Practitioner in Oncology|August 1, 2026
Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty PharmacyUmesh Yogarajah, Thuy Tran, Erin Cichonski, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 9, 2019
A review of R-DHAP administration in the outpatient setting and a case of the alternative regimen R-DHAX given outpatient for refractory diffuse large B-cell lymphomaHailey Hill, Justin Arnall, Amanda Janes, et al.Transplantation and Cellular Therapy|November 6, 2024
Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell TransplantationMiranda Benfield, Jiaxian He, Justin Arnall, et al.Pageof 2